Governments, industry, and regulators are looking to use blockchain technology to improve the pharmaceutical supply chain. Blockchain creates an immutable record of all events, allowing for the safe and automated transfer of information. The cost of counterfeit drugs is significant, with up to 30% of antimalarials in sub-Saharan Africa estimated to be fake. Companies like Merck and Novartis are exploring blockchain’s use, and the US FDA has launched a pilot program. However, there are challenges to widespread adoption, such as a lack of common standards and legal barriers.
Gem Security announces $23 Mn in Series A funding, CIOSEA News, ETCIO SEA
Cloud Detection and Response (CDR) company, Gem Security, has raised $23m in an oversubscribed Series A funding round. The round was led by GGV Capital
